Bringing diagnostic-grade cardiac monitoring into the challenging environment of an MRI machine, MiRTLE Medical LLC has secured $590K in Seed funding. The capital infusion will support the company's work in developing medical devices and software solutions that enable 12-lead ECG monitoring during MRI scans.
MiRTLE Medical's technology aims to improve patient outcomes and expand clinical procedures by providing a comprehensive set of tools for cardiologists, electrophysiologists, and radiologists, offering crucial diagnostic data where it was once difficult to obtain.
